Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 33

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

The 7-amino-acid site in the proline-rich region of the N-terminal domain of p53 is involved in the interaction with FAK and is critical for p53 functioning

Golubovskaya, Vita M., Finch, Richard, Zheng, Min, Kurenova, Elena V., Cance, William G.·2008·Biochemical Journal

Abstract

It is known that p53 alterations are commonly found in tumour cells. Another marker of tumorigenesis is FAK (focal adhesion kinase), a non-receptor kinase that is overexpressed in many types of tumours. Previously we determined that the N-terminal domain of FAK physically interacted with the N-terminal domain of p53. In the present study, using phage display, site-directed mutagenesis, pulldown and immunoprecipitation assays we localized the site of FAK binding to a 7-amino-acid region (amino acids 65–71) in the N-terminal proline-rich domain of human p53. Mutation of the binding site in p53 reversed the suppressive effect of FAK on p53-mediated transactivation of p21, BAX (Bcl-2-associated X protein) and Mdm2 (murine double minute 2) promoters. In addition, to functionally test this p53 site, we conjugated p53 peptides [wild-type (containing the wild-type binding site) and mutant (with a mutated 7-amino-acid binding site)] to a TAT peptide sequence to penetrate the cells, and demonstrated that the wild-type p53 peptide disrupted binding of FAK and p53 proteins and significantly inhibited cell viability of HCT116 p53+/+ cells compared with the control mutant peptide and HCT116 p53−/− cells. Furthermore, the TAT–p53 peptide decreased the viability of MCF-7 cells, whereas the mutant peptide did not cause this effect. Normal fibroblast p53+/+ and p53−/− MEF (murine embryonic fibroblast) cells and breast MCF10A cells were not sensitive to p53 peptide. Thus, for the first time, we have identified the binding site of the p53 and FAK interaction and have demonstrated that mutating this site and targeting the site with peptides affects p53 functioning and viability in the cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/bj20071657

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 35

  1. Hanks, 1997, Signaling through focal adhesion kinase, BioEssays, 19, 137, 10.1002/bies.950190208 · DOI · Paper page
  2. Mitra, 2006, Integrin-regulated FAK-Src signaling in normal and cancer cells, Curr. Opin. Cell Biol., 18, 516, 10.1016/j.ceb.2006.08.011 · DOI · Paper page
  3. McLean, 2005, The role of focal-adhesion kinase in cancer: a new therapeutic opportunity, Nat. Rev. Cancer, 5, 505, 10.1038/nrc1647 · DOI · Paper page
  4. Cance, 2000, Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes, Clin. Cancer Res., 6, 2417
  5. Cance, 1995, Protein kinases in human breast cancer, Breast Cancer Res. Treat., 35, 105, 10.1007/BF00694751 · DOI
  6. Owens, 1995, Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors, Cancer Res., 55, 2752
  7. Lark, 2003, Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses, Clin. Cancer Res., 9, 215
  8. Lightfoot, 2004, Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis, Breast Cancer Res. Treat., 88, 109, 10.1007/s10549-004-1022-8 · doi:10.1007/s10549-004-1022-8
  9. Golubovskaya, 2004, Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor κB and p53 binding sites, Biochim. Biophys. Acta, 1678, 111, 10.1016/j.bbaexp.2004.03.002 · DOI
  10. Schaller, 2001, Paxillin: a focal adhesion-associated adaptor protein, Oncogene, 20, 6459, 10.1038/sj.onc.1204786 · DOI · Paper page
  11. Schaller, 1994, Focal adhesion kinase and associated proteins, Curr. Opin. Cell Biol., 6, 705, 10.1016/0955-0674(94)90097-3 · DOI · Paper page
  12. Garces, 2006, Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells, Cancer Res., 66, 1446, 10.1158/0008-5472.CAN-05-1661 · DOI
  13. Hauck, 2001, Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells, Cancer Res., 61, 7079
  14. Golubovskaya, 2002, Dual inhibition of focal adhesion kinase and epidermal growth factor receptor pathways cooperatively induces death receptor-mediated apoptosis in human breast cancer cells, J. Biol. Chem., 277, 38978, 10.1074/jbc.M205002200 · DOI
  15. Chen, 2006, Direct interaction of focal adhesion kinase (FAK) with Met is required for FAK to promote hepatocyte growth factor-induced cell invasion, Mol. Cell. Biol., 26, 5155, 10.1128/MCB.02186-05 · DOI
  16. Kurenova, 2004, Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein, Mol. Cell. Biol., 24, 4361, 10.1128/MCB.24.10.4361-4371.2004 · DOI · Paper page
  17. Kadare, 2003, PIAS1-mediated sumoylation of focal adhesion kinase activates its autophosphorylation, J. Biol. Chem., 278, 47434, 10.1074/jbc.M308562200 · DOI
  18. Golubovskaya, 2005, Direct interaction of the N-terminal domain of focal adhesion kinase with the N-terminal transactivation domain of p53, J. Biol. Chem., 280, 25008, 10.1074/jbc.M414172200 · DOI · Paper page
  19. Golubovskaya, 2007, Focal adhesion kinase and p53 signaling in cancer cells, Int. Rev. Cytol., 263, 103, 10.1016/S0074-7696(07)63003-4 · DOI
  20. Zhang, 2004, Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis: fibronectin and integrin αV mediate survival signals through focal adhesion kinase, J. Biol. Chem., 279, 48342, 10.1074/jbc.M407953200 · DOI
  21. Livasy, 2004, Focal adhesion kinase overexpression in endometrial neoplasia, Appl. Immunohistochem. Mol. Morphol., 12, 342, 10.1097/00129039-200412000-00009 · DOI
  22. Lieman, 2005, Loss of Rb-E2F repression results in caspase-8 mediated apoptosis through inactivation of focal adhesion kinase, J. Biol. Chem., 280, 10484, 10.1074/jbc.M409371200 · DOI
  23. Toledo, 2007, Mouse mutants reveal that putative protein interaction sites in the p53 proline-rich domain are dispensable for tumor suppression, Mol. Cell. Biol., 27, 1425, 10.1128/MCB.00999-06 · DOI · Paper page
  24. Venot, 1998, The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression, EMBO J., 17, 4668, 10.1093/emboj/17.16.4668 · DOI · Paper page
  25. Zhu, 2000, Definition of the p53 functional domains necessary for inducing apoptosis, J. Biol. Chem., 275, 39927, 10.1074/jbc.M005676200 · DOI
  26. Baptiste, 2002, The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells, Oncogene, 21, 9, 10.1038/sj.onc.1205015 · DOI
  27. Jiang, 2001, p53 binds the nuclear matrix in normal cells: binding involves the prolinerich domain of p53 and increases following genotoxic stress, Oncogene, 20, 5449, 10.1038/sj.onc.1204705 · DOI · Paper page
  28. Chen, 2001, Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain, Nat. Cell. Biol., 3, 439, 10.1038/35074500 · DOI
  29. Jiang, 2004, Bi-directional regulation between tyrosine kinase Etk/BMX and tumor suppressor p53 in response to DNA damage, J. Biol. Chem., 279, 50181, 10.1074/jbc.M409108200 · DOI
  30. van Heemst, 2005, Variation in the human TP53 gene affects old age survival and cancer mortality, Exp. Gerontol., 40, 11, 10.1016/j.exger.2004.10.001 · DOI · Paper page
  31. Chen, 1993, Mapping of the p53 and mdm-2 interaction domains, Mol. Cell. Biol., 13, 4107
  32. Wu, 1993, The p53-mdm-2 autoregulatory feedback loop, Genes Dev., 7, 1126, 10.1101/gad.7.7a.1126 · DOI · Paper page
  33. Xu, 2000, The focal adhesion kinase suppresses transformation-associated, anchorage-independent apoptosis in human breast cancer cells, J. Biol. Chem., 275, 30597, 10.1074/jbc.M910027199 · DOI · Paper page
  34. Golubovskaya, 2007, TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR, Mol. Carcin.
  35. Martin, 2001, Human MCF10A mammary epithelial cells undergo apoptosis following actin depolymerization that is independent of attachment and rescued by Bcl-2, Mol. Cell. Biol., 21, 6529, 10.1128/MCB.21.19.6529-6536.2001 · DOI

Cited by

See all 33

Metadata

Authors
Golubovskaya, V. M., Finch, R., Zheng, M., Kurenova, E. V., & Cance, W. G.
Affiliations
Department of Surgery, University of Florida, Gainesville, FL 32610, U.S.A.
Venue
Biochemical Journal
Published
2008-03-13
Volume
411
Issue
1
Pages
151-160
ISSN
  • 0264-6021
  • 1470-8728
Cited by
33
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The 7-amino-acid site in the proline-rich region of the N-terminal domain of p53 is involved in the interaction with FAK and is critical for p53 functioning. https://app.cochat.ai/papers/10.1042/bj20071657
The paper
Golubovskaya, V. M., Finch, R., Zheng, M., Kurenova, E. V., & Cance, W. G. (2008). The 7-amino-acid site in the proline-rich region of the N-terminal domain of p53 is involved in the interaction with FAK and is critical for p53 functioning. Biochemical Journal. https://doi.org/10.1042/bj20071657

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.